Abstract
D Objective: An evaluation of the safety of poly-ADP-ribose-polymerase inhibitors (PARPi) in ovarian cancer treatment. Methods: An analysis of the stu......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
